Five observations:
1. Healthcare companies raised $8.8 billion worldwide from April 1 to May 24, 2020. There were 672 deals during that time.
2. Healthcare is on pace to close the second quarter with more than $15 billion in funding and 1,180 deals, which would be one of the strongest quarters over the past three years.
3. Funding in the second quarter could be up 6 percent over the first quarter and 11 percent year-over-year for healthcare companies, if current projections hold true.
4. Healthcare companies in North America are reporting a funding dip while companies based in Asia and Europe are seeing funding increase. Projected funding for North American companies is $8.9 million, down from $10.3 million in the second quarter.
5. There were 14 companies that had mega-rounds of funding in the second quarter through May 24, including Erasca, which closed a $200 million series B funding round. The biggest deal for a U.S.-based digital health company is Amwell’s $194 million funding round.
More articles on digital transformation:
Northwell Health, University Hospitals join $12M funding round for virtual care company
Cleveland Clinic Ventures had 7 spinoffs, invested $10M in 10 companies last year
Only 12% of CFOs expect to cut, defer digital transformation spending: survey
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
